DEF 14AIDXGCIK 0001054102

INTERPACE BIOSCIENCES, INC.

Name: SEC EDGAR filing 0001493152-24-037669
Creator: INTERPACE BIOSCIENCES, INC.
License: https://www.usa.gov/government-works

Proxy statement (DEF 14A) filed September 20, 2024.

Definitive proxy statement disclosing matters to be voted on by shareholders, including executive compensation.

Read the filing on SEC.gov All documents in this filing

New to the DEF 14A? What it is and how to read one

Filing facts

Accession number: 0001493152-24-037669
Filer: INTERPACE BIOSCIENCES, INC.
Ticker: IDXG
CIK: 0001054102
Form type: DEF 14A
Form description: Proxy statement
Filed at: September 20, 2024
Period of report: September 20, 2024
Industry: SIC 3841Surgical & Medical Instruments
Filing size: 1.9 MB
Last verified: August 26, 2026SecFilingDex pulls from EDGAR with daily cadence

More filings from INTERPACE BIOSCIENCES, INC.

See all 42 filings from INTERPACE BIOSCIENCES, INC. →

Provenance

Authoritative source — SEC EDGAR

https://www.sec.gov/Archives/edgar/data/1054102/000149315224037669/0001493152-24-037669-index.htm ↗

Filer's full EDGAR submission history

EDGAR · INTERPACE BIOSCIENCES, INC. (0001054102) ↗

SecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.